GSK Pharma names Sukanya Choudhury as Regulatory Head, Growth Emerging Markets

GlaxoSmithKline Pharmaceuticals Limited has announced that Sukanya Choudhury, Executive Vice President - Regulatory Affairs has taken a secondment role as Regulatory Head, Growth Emerging Markets for period of 16 months with effect from 1st May 2025.

Pursuant to her secondment, she will also cease to be the Senior Management Personnel of the Company effective the same date.

Read also: GSK Arexvy recommended for adults aged 50-59 at increased risk for severe RSV disease by US Advisory Committee on Immunization Practices

Choudhury has had a distinguished career with GSK, which she joined in 2007 as Senior Manager – Regulatory Affairs. Over the years, she rose through the ranks, becoming General Manager – Regulatory Affairs in 2013, and later promoted to Vice President – Regulatory Affairs in 2016.

She began her professional journey with East India Pharmaceutical Works Ltd in 1998, and went on to hold roles at Alembic Pharmaceuticals, Eli Lilly, and Boston Scientific.

Read also: GSK Arexvy recommended for adults aged 50-59 at increased risk for severe RSV disease by US Advisory Committee on Immunization Practices